Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
Launched by YALE UNIVERSITY · May 23, 2016
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how cannabis, specifically a compound called Delta-9-Tetrahydrocannabinol (THC), affects men and women differently. The researchers want to understand the immediate effects of THC on healthy people and explore why there might be differences between genders. This study is currently recruiting participants aged between 65 and 88, and everyone is welcome to join as long as they have tried cannabis at least once in their life and are in good physical and mental health.
To participate, you should have some experience with cannabis and not currently be dealing with major life stressors. Women who are on estrogen supplements or birth control pills are not eligible for this trial. If you join, you can expect to be part of a study that helps researchers learn more about how cannabis works in the body, which could lead to better understanding and treatment options in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at least one lifetime exposure to cannabis
- • good physical and mental health
- Exclusion Criteria:
- • cannabis naive individuals
- • major current or recent stressors
- • taking estrogen supplements or oral contraceptive pills (for women)
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
West Haven, Connecticut, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials